IL85576A0 - Activated rnase l as a marker for virus infections - Google Patents

Activated rnase l as a marker for virus infections

Info

Publication number
IL85576A0
IL85576A0 IL85576A IL8557688A IL85576A0 IL 85576 A0 IL85576 A0 IL 85576A0 IL 85576 A IL85576 A IL 85576A IL 8557688 A IL8557688 A IL 8557688A IL 85576 A0 IL85576 A0 IL 85576A0
Authority
IL
Israel
Prior art keywords
pathway
rnase
aids
biochemical
inhibitor
Prior art date
Application number
IL85576A
Other languages
English (en)
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of IL85576A0 publication Critical patent/IL85576A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/922—Ribonucleases (RNAses); Deoxyribonucleases (DNAses)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL85576A 1987-03-03 1988-02-29 Activated rnase l as a marker for virus infections IL85576A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2137287A 1987-03-03 1987-03-03

Publications (1)

Publication Number Publication Date
IL85576A0 true IL85576A0 (en) 1988-08-31

Family

ID=21803819

Family Applications (1)

Application Number Title Priority Date Filing Date
IL85576A IL85576A0 (en) 1987-03-03 1988-02-29 Activated rnase l as a marker for virus infections

Country Status (20)

Country Link
EP (1) EP0285263B1 (xx)
JP (1) JPH0675520B2 (xx)
KR (1) KR880011593A (xx)
AT (1) ATE107964T1 (xx)
AU (1) AU618525B2 (xx)
CA (1) CA1337278C (xx)
DE (1) DE3850428T2 (xx)
DK (1) DK112888A (xx)
ES (1) ES2058252T3 (xx)
FI (1) FI880959A (xx)
IE (1) IE66831B1 (xx)
IL (1) IL85576A0 (xx)
MX (1) MX173802B (xx)
NO (1) NO880934L (xx)
NZ (1) NZ223721A (xx)
OA (1) OA08720A (xx)
PH (1) PH30882A (xx)
PT (1) PT86878B (xx)
RU (1) RU2049336C1 (xx)
ZA (1) ZA881471B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
DE3853755T2 (de) * 1987-09-04 1995-12-14 Hem Pharma Corp Diagnose von Mangelzuständen doppelsträngiger RNS.
AU724056B2 (en) * 1987-09-04 2000-09-14 Hem Research, Inc. Diagnosis and treatment of double stranded deficiency states
ATE103493T1 (de) * 1988-07-07 1994-04-15 Hem Pharma Corp Diagnose und behandlung chronischer ermuedungserscheinungen.
US5985565A (en) * 1996-10-09 1999-11-16 Temple University-Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6207366B1 (en) 1999-04-14 2001-03-27 Temple University- Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6080554A (en) * 1999-04-27 2000-06-27 R.E.D. Laboratories, N.V. Methods and compositions for use in characterizing multiple sclerosis disease activity in a subject
WO2017193051A1 (en) * 2016-05-06 2017-11-09 The Trustees Of Princeton University Methods of monitoring rnase l activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
IE880587L (en) 1988-09-03
DK112888D0 (da) 1988-03-02
DE3850428T2 (de) 1994-11-24
PT86878B (pt) 1992-05-29
PT86878A (pt) 1988-04-01
NO880934L (no) 1988-09-05
PH30882A (en) 1997-12-23
CA1337278C (en) 1995-10-10
AU618525B2 (en) 1992-01-02
ATE107964T1 (de) 1994-07-15
NZ223721A (en) 1991-02-26
EP0285263A2 (en) 1988-10-05
OA08720A (en) 1989-03-31
DK112888A (da) 1988-09-04
EP0285263B1 (en) 1994-06-29
JPH0675520B2 (ja) 1994-09-28
NO880934D0 (no) 1988-03-02
AU1256388A (en) 1988-09-01
RU2049336C1 (ru) 1995-11-27
JPS63309200A (ja) 1988-12-16
FI880959A0 (fi) 1988-03-02
DE3850428D1 (de) 1994-08-04
ES2058252T3 (es) 1994-11-01
EP0285263A3 (en) 1990-04-18
ZA881471B (en) 1988-12-28
KR880011593A (ko) 1988-10-29
MX173802B (es) 1994-03-29
IE66831B1 (en) 1996-02-07
FI880959A (fi) 1988-09-04

Similar Documents

Publication Publication Date Title
WO1994023041A3 (en) Method for selective inactivation of viral replication
EP0944807A4 (en) CONNECTED BOW WITH COUNTERWEIGHT
EP0285263A3 (en) Activated rnase l as a marker for virus infections
ES476148A1 (es) Un procedimiento para la preparacion de macrolidas
NZ228645A (en) 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections
WO1993017651A3 (de) Antivirale nucleosidanaloge, ihre herstellung und ihre verwendung
FI883763A0 (fi) Frigoering av vaerdens foersvarsmediatorer i biologiska vaetskor genom systematisk behandling med dubbelstraengat rna.
ES8708243A1 (es) Un procedimiento para preparar un copolimero de bloques de un hidrocarburo monoalquenilaromatico polimerizado y un hidrocarburo dienico conjugado polimerizado
BR0005799A (pt) Sistema hidráulico
AU590817B2 (en) Antiviral combinations
MY106304A (en) Antiviral combinations and compounds therefor.
IL85603A0 (en) Synergistic interplay of lymphokines and double-stranded rnas
IT8709410A0 (it) Arma giocattolo per il lancio pneumatico di proiettili,con il pistone del sistema cilindropistone combinato al cane,dell'arma
EP0034424A3 (en) Seven-membered ring compounds as inhibitors of cytidine deaminase
DE60128565D1 (en) Polycyclische xanthone als antibiotika
EP0335770A3 (en) Novel fluorophosphonate nucleotide derivatives
EP0325462A3 (en) Anthelmintic milbemycin derivatives
WO1988007080A3 (en) Transgenic animal cells resistant to viral infection
ES2053601T3 (es) Agentes de biocontrol fundidos.
NO985110L (no) Eksplosivformuleringer
AR247215A1 (es) Un procedimiento para producir un antibiotico antifungico y antiviral, n-acetilbenanomicina b.
SE8702004D0 (sv) Rotasjonsprosjektil med et hult neseparti
McKercher Assay of Experimental Transmission With an Argaside(Ornithodoros coriaceus), of a Chlamydia, Associated With Bovine Abortion.
NO985112L (no) Eksplosivformuleringer
ES2007988A6 (es) Procedimiento de obtencion de un derivado de guanina.